Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy

https://doi.org/10.1016/0360-3016(85)90372-4Get rights and content

Abstract

Between 1970 and 1981, 436 patients with T1 and small T2 breast carcinoma were treated by tumor excision followed by radiotherapy at the Institut Gustave-Roussy. The mean follow-up was 5 years, with 50% of patients followed 5 years. Twenty-four patients have experienced a local-regional (LR) relapse for an actuarial LR control rate of 93% at 5 years and 90% at 10 years. Potential prognostic factors for all 24 local-regional recurrences and for the subgroup with relapses in the breast were analyzed. A high Bloom grade and a low Nominal Standard Dose (NSD) were significant prognostic factors for predicting LR relapse in both groups. Disease-free survival (from initial presentation) was not adversely affected by a solitary breast recurrence, when patients with successful salvage treatment were considered disease free. However, the group of patients with nodal or dermal recurrences had a much worse prognosis. This paper describes the natural history of breast cancer following a local-regional relapse in irradiated patients without mastectomy. Most importantly, we observed that breast relapses following radiotherapy become clinically apparent more slowly than chest wall failures after mastectomy, and if detected early, that these patients may be successfully retreated.

References (33)

  • R. Calle et al.

    Conservative management of operable breast cancer. Ten years experience of the Foundation Curie

    Cancer

    (1978)
  • F.C.H. Chu et al.

    Locally recurrent carcinoma of the breast. Results of radiation therapy

    Cancer

    (1976)
  • J.L. Connolly et al.

    Pathologic correlates of local tumor control following primary radiation therapy in patients with early breast cancer

  • D.R. Cox

    Regression models and life tables

    J.R. Statis. Soc.

    (1972)
  • F. Ellis

    Relationship of biological effect to dose-timefractionation factors in radiotherapy

  • B. Fisher et al.

    Cancer and the breast: Size of the neoplasm and prognosis

    Cancer

    (1969)
  • Cited by (391)

    • Intraoperative evaluation of surgical margins in breast conserving therapy

      2018, The Breast: Comprehensive Management of Benign and Malignant Diseases
    • Breast conservation therapy for invasive breast cancer

      2018, The Breast: Comprehensive Management of Benign and Malignant Diseases
    • NRG Oncology–Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence

      2017, International Journal of Radiation Oncology Biology Physics
      Citation Excerpt :

      This has become accepted for reasons including the perception that mastectomy is the only logical next step, concerns over cosmetic outcomes after additional surgery, and complication rates after additional radiation therapy. Published outcomes suggest that a mastectomy may not be the definitive answer, because chest wall failure rates after a mastectomy for in-breast failure after WBI range from 3% to 32% (2-15) (Table 1). It is recognized that these are older series with variable follow-up and that the stage at presentation, in-breast recurrence extent, and surgical details are not available to allow a modern perspective regarding anticipated chest wall recurrence rates.

    View all citing articles on Scopus

    Funded by Institut National de la Sante et de la Recherche Medicale (INSERM), Paris.

    Currently at the Department of Radiation Oncology, Fresno Community Hospital, Fresno, CA.

    View full text